Polysaccharide-K (PSK) in cancer - Old story, new possibilities?

Current Medicinal Chemistry

Volumn 19, Issue 5, 2012, Pages 757-762

  Sun, C ^a,b   Rosendahl, A H ^a   Wang, X D ^c   Wu, D Q ^b   Andersson, R ^a  

^a LUND UNIVERSITY   (Sweden)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

CAM; Cancer; Immune activation; Immunology; Krestin; Mechanism; Medicinal mushroom; Polysaccharide K; PSK; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOCETAXEL; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HEAT SHOCK PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; IRINOTECAN; KRESTIN; MELANOIDINE; MITOMYCIN C; PREDNISOLONE; TEGAFUR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UFT; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CANCER THERAPY; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL COMPOSITION; COLORECTAL CANCER; CRYOABLATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DISTANT METASTASIS; DRUG EFFECT; DRUG POTENTIATION; DRUG STRUCTURE; ESOPHAGUS CANCER; GENE EXPRESSION PROFILING; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LIVER CANCER; LIVER METASTASIS; LUNG CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MOLECULAR WEIGHT; MULTIPLE CYCLE TREATMENT; NONHUMAN; PANCREAS CANCER; PERITONEUM MACROPHAGE; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOMA; T LYMPHOCYTE ACTIVATION;

AGARICALES; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; PLANT EXTRACTS; PROTEOGLYCANS;

EID: 84863284114     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712798992020     Document Type: Review

References (59)

1. World Health Organization. Causes of death 2008: Data sources and methods. http://www.who.int/healthinfo/global-burden-disease/cod-2008-sources-me thods.pdf (accessed Aug 3, 2011).
2. Fisher, M.; Yang, L.X. Anticancer effects and mechanisms of polysaccharide-K (PSK): Implications of cancer immunotherapy. Anticancer Res., 2002, 22, 1737-1754 (Pubitemid 34839190)
3. Hirase, S.; Nakai, S.; Akatsu, T.; Kobayashi, A.; Oohara, M. [Structural studies on the anti-tumor active polysaccharides from Coriolus versicolor (Basidiomycetes). II. Structures of beta-D-glucan moieties of fractionated polysaccharides (author's transl)]. Yakugaku Zasshi, 1976, 96, 419-424
4. Miyazaki, T.; Yadomae, T.; Sugiura, M.; Ito, H.; Fujii, K. Chemical structure of antitumor polysaccharide, coriolan, produced by Coriolus versicolor. Chem. Pharm. Bull. (Tokyo), 1974, 22, 1739-1742
5. Sullivan, R.; Smith, J.E.; Rowan, N.J. Medicinal mushrooms and cancer therapy: Translating a traditional practice into Western medicine. Perspect. Biol. Med., 2006, 49, 159-170
6. Tsukagoshi, S.; Hashimoto, Y.; Fujii, G.; Kobayashi, H.; Nomoto, K.; Orita, K. Krestin (PSK). Cancer Treat. Rev., 1984, 11, 131-155 (Pubitemid 16004444)
7. Boh, B.; Berovic, M.; Zhang, J.; Zhi-Bin, L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol. Annu. Rev., 2007, 13, 265-301 (Pubitemid 47387127)
8. Wasser, S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biotechnol., 2002, 60, 258-274
9. Jimenez, E.; Garcia-Lora, A.; Martinez, M.; Garrido, F. Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells. Cancer Immunol. Immunother., 2005, 54, 395-399 (Pubitemid 40246339)
10. Sadahiro, S.; Suzuki, T.; Maeda, Y.; Tanaka, A.; Kamijo, A.; Murayama, C.; Nakayama, Y.; Akiba, T. Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma. Anticancer Res., 2010, 30, 993-999
11. Akagi, J.; Baba, H. PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients. Int. J. Clin. Oncol., 2010, 15, 145-152
12. Ohwada, S.; Ogawa, T.; Makita, F.; Tanahashi, Y.; Ohya, T.; Tomizawa, N.; Satoh, Y.; Kobayashi, I.; Izumi, M.; Takeyoshi, I.; Hamada, K.; Minaguchi, S.; Togo, Y.; Toshihiko, T.; Koyama, T.; Kamio, M. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: Analysis of immunological parameters. Oncol. Rep., 2006, 15, 861-868
13. Iino, Y.; Yokoe, T.; Maemura, M.; Takei, H.; Horiguchi, J.; Morishita, Y. A New Endocrine Therapy Strategy for Bone Metastasis of Breast Cancer: The Effect of Biological Response Modifiers and 22-Oxacarcitriol on Animal Models. Breast Cancer, 1997, 4, 311-313
14. Yokoe, T.; Iino, Y.; Takei, H.; Horiguchi, J.; Koibuchi, Y.; Maemura, M.; Ohwada, S.; Morishita, Y. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. Anticancer Res., 1997, 17, 2815-2818 (Pubitemid 27352693)
15. Ogihara, H.; Takenoshita, S.; Yajima, Y.; Shinozaki, K.; Takahiro, K.; Asao, T.; Nagamachi, Y. The efficacy of immunochemotherapy with strontium (Sr) in the 1,2-dimethylhydrazine (DMH) induced rat carcinogenetic model: Ultrastructural characteristics of the mitochondria in the liver. Anticancer Res., 1998, 18, 159-164 (Pubitemid 28174700)
16. Zhang, H.; Morisaki, T.; Nakahara, C.; Matsunaga, H.; Sato, N.; Nagumo, F.; Tadano, J.; Katano, M. PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene, 2003, 22, 2088-2096 (Pubitemid 36539559)
17. Zhang, H.; Morisaki, T.; Matsunaga, H.; Sato, N.; Uchiyama, A.; Hashizume, K.; Nagumo, F.; Tadano, J.; Katano, M. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGFbeta1 and MMPs. Clin. Exp. Metastasis, 2000, 18, 343-352 (Pubitemid 32579404)
18. Horimi, T.; Takasaki, M.; Toki, A.; Nishimura, W.; Morita, S. The beneficial effect of tamoxifen therapy in patients with resected adenocarcinoma of the pancreas. Hepato-Gastroenterology, 1996, 43, 1225-1229 (Pubitemid 26358518)
19. Yamasaki, A.; Shoda, M.; Iijima, H.; Nagai, S.; Wada, J.; Suzuki, H.; Chikazawa, N.; Tasaka, T.; Kameda, C.; Tanaka, H.; Ikebe, M.; Jo, E.; Sato, N.; Nakamura, M.; Sekine, F.; Morisaki, T.; Katano, M. A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. Anticancer Res., 2009, 29, 843-850
20. Oba, K.; Teramukai, S.; Kobayashi, M.; Matsui, T.; Kodera, Y.; Sakamoto, J. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol. Immunother., 2007, 56, 905-911 (Pubitemid 46729147)
21. Shibata, M.; Nezu, T.; Fujisaki, S.; Andou, K.; Tomita, R.; Fukuzawa, M. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience. Dig. Surg., 2002, 19, 255-260 (Pubitemid 35013723)
22. Okuzawa, M.; Shinohara, H.; Kobayashi, T.; Iwamoto, M.; Toyoda, M.; Tanigawa, N. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro. Int. J. Oncol., 2002, 20, 1189-1195
23. Okudaira, Y.; Sugimachi, K.; Inokuchi, K.; Kai, H.; Kuwano, H.; Matsuura, H. Postoperative long-term immunochemotherapy for esophageal carcinoma. 5 year survival. Jpn. J. Surg., 1982, 12, 249-256 (Pubitemid 13227106)
24. Jimenez-Medina, E.; Berruguilla, E.; Romero, I.; Algarra, I.; Collado, A.; Garrido, F.; Garcia-Lora, A. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer, 2008, 8, 78
25. Hayakawa, K.; Mitsuhashi, N.; Saito, Y.; Takahashi, M.; Katano, S.; Shiojima, K.; Furuta, M.; Niibe, H. Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with nonsmall cell lung cancer. Anticancer Res., 1993, 13, 1815-1820
26. Hayakawa, K.; Mitsuhashi, N.; Saito, Y.; Nakayama, Y.; Furuta, M.; Nakamoto, S.; Kawashima, M.; Niibe, H. Effect of Krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients. Cancer Detect. Prev., 1997, 21, 71-77 (Pubitemid 27307074)
27. Katoh, R.; Takenoshita, S.; Shimizu, Y.; Tanaka, S.; Yajima, Y.; Nagamachi, Y. Changes in serum soluble IL-2 receptors (sIL-2R) and immunosuppressive acidic protein (IAP) associated with chemotherapy for lung cancer. Anticancer Res., 1997, 17, 3787-3792 (Pubitemid 28014941)
28. Jong, S.C.; Donovick, R. Antitumor and antiviral substances from fungi. Adv. Appl. Microbiol., 1989, 34, 183-262
29. Price, L.A.; Wenner, C.A.; Sloper, D.T.; Slaton, J.W.; Novack, J.P. Role for toll-like receptor 4 in TNF-Alpha secretion by murine macrophages in response to polysaccharide Krestin, a Trametes versicolor mushroom extract. Fitoterapia, 2010, 81, 914-919
30. Lu, H.; Yang, Y.; Gad, E.; Wenner, C.A.; Chang, A.; Larson, E.R.; Dang, Y.; Martzen, M.; Standish, L.J.; Disis, M.L. Polysaccharide Krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clin. Cancer Res., 2010
31. Kanazawa, M.; Mori, Y.; Yoshihara, K.; Iwadate, M.; Suzuki, S.; Endoh, Y.; Ohki, S.; Takita, K.; Sekikawa, K.; Takenoshita, S. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol. Lett., 2004, 91, 229-238 (Pubitemid 38296383)
32. Liu, A.; Arbiser, J.L.; Holmgren, A.; Klein, G.; Klein, E. PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. Blood, 2005, 105, 1606-1613 (Pubitemid 40223681)
33. Ohmura, Y.; Matsunaga, K.; Suzuki, T. Protective effect of a protein-bound polysaccharide, PSK, on CLP-induced sepsis in mice transplanted orthotopically with colon tumor. Shock, 2006, 25, 36-42
34. Shibata, M.; Nezu, T.; Kanou, H.; Nagata, Y.; Kimura, T.; Takekawa, M.; Ando, K.; Fukuzawa, M. Immunomodulatory effects of low dose cis- Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Invest., 2002, 20, 166-173 (Pubitemid 34205482)
35. Asai, H.; Iijima, H.; Matsunaga, K.; Oguchi, Y.; Katsuno, H.; Maeda, K. Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling. Cancer Immunol. Immunother., 2008, 57, 1647-1655
36. Kono, K.; Kawaguchi, Y.; Mizukami, Y.; Mimura, K.; Sugai, H.; Akaike, H.; Fujii, H. Protein-bound polysaccharide K partially prevents apoptosis of circulating T cells induced by anti-cancer drug S-1 in patients with gastric cancer. Oncology, 2008, 74, 143-149
37. Maruyama, S.; Akasaka, T.; Yamada, K.; Tachibana, H. Protein-bound polysaccharide-K (PSK) directly enhanced IgM production in the human B cell line BALL-1. Biomed. Pharmacother., 2009, 63, 409-412
38. Matsunaga, K.; Hosokawa, A.; Oohara, M.; Sugita, N.; Harada, M.; Nomoto, K. Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-beta. Immunopharmacology, 1998, 40, 219-230 (Pubitemid 28522180)
39. Yamaguchi, Y.; Minami, K.; Ohshita, A.; Kawabuchi, Y.; Noma, K.; Toge, T. Enhancing effect of PS-K on IL-2-induced lymphocyte activation: Possible involvement of antagonistic action against TGF-beta. Anticancer Res., 2004, 24, 639-647 (Pubitemid 38625001)
40. Habelhah, H.; Okada, F.; Nakai, K.; Choi, S.K.; Hamada, J.; Kobayashi, M.; Hosokawa, M. Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: Possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K. Cancer Immunol. Immunother., 1998, 46, 338-344 (Pubitemid 28410580)
41. Pang, Z.J.; Chen, Y.; Zhou, M. Polysaccharide Krestin enhances manganese superoxide dismutase activity and mRNA expression in mouse peritoneal macrophages. Am. J. Chin. Med., 2000, 28, 331-341
42. Harada, M.; Matsunaga, K.; Oguchi, Y.; Iijima, H.; Tamada, K.; Abe, K.; Takenoyama, M.; Ito, O.; Kimura, G.; Nomoto, K. Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gutassociated lymphoid tissue (GALT) of specific-pathogen-free mice. Int. J. Cancer, 1997, 70, 362-372 (Pubitemid 27099608)
43. Kamei, H.; Hashimoto, Y.; Koide, T.; Kojima, T.; Hasegawa, M.; Umeda, T. Direct tumor growth suppressive effect of melanoidin extracted from immunomodulator-PSK. Cancer Biother. Radiopharm., 1997, 12, 341-344 (Pubitemid 28009377)
44. Hattori, T.S.; Komatsu, N.; Shichijo, S.; Itoh, K. Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa. Biomed. Pharmacother., 2004, 58, 226-230 (Pubitemid 38746748)
45. Matsunaga, K.; Iijima, H.; Kobayashi, H. Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 1313-1322 (Pubitemid 32044799)
46. Iguchi, C.; Nio, Y.; Takeda, H.; Yamasawa, K.; Hirahara, N.; Toga, T.; Itakura, M.; Tamura, K. Plant polysaccharide PSK: Cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface. Anticancer Res., 2001, 21, 1007-1013
47. Yoshikawa, R.; Yanagi, H.; Hashimoto-Tamaoki, T.; Morinaga, T.; Nakano, Y.; Noda, M.; Fujiwara, Y.; Okamura, H.; Yamamura, T. Gene expression in response to anti-tumour intervention by polysaccharide-K (PSK) in colorectal carcinoma cells. Oncol. Rep., 2004, 12, 1287-1293
48. Ohmura, Y.; Matsunaga, K.; Motokawa, I.; Sakurai, K.; Ando, T. Protective effects of a protein-bound polysaccharide, PSK, against Candida albicans infection in syngeneic tumor-bearing mice via Th1 cell functions. Cancer Biother. Radiopharm., 2003, 18, 769-780 (Pubitemid 37377312)
49. Urano, M.; Tanaka, C.; Sugiyama, Y.; Miya, K.; Saji, S. Antitumor effects of residual tumor after cryoablation: The combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology, 2003, 46, 238-245 (Pubitemid 36724565)
50. Morino, M.; Tsuzuki, T.; Ishikawa, Y.; Shirakami, T.; Yoshimura, M.; Kiyosuke, Y.; Matsunaga, K.; Yoshikumi, C.; Saijo, N. Specific regulation of HSPs in human tumor cell lines by PSK. In Vivo, 1997, 11, 261-264 (Pubitemid 27348113)
51. Ohwada, S.; Ikeya, T.; Yokomori, T.; Kusaba, T.; Roppongi, T.; Takahashi, T.; Nakamura, S.; Kakinuma, S.; Iwazaki, S.; Ishikawa, H.; Kawate, S.; Nakajima, T.; Morishita, Y. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: A randomised controlled study. Br. J. Cancer, 2004, 90, 1003-1010 (Pubitemid 38495819)
52. Sakai, T.; Yamashita, Y.; Maekawa, T.; Mikami, K.; Hoshino, S.; Shirakusa, T. Immunochemotherapy with PSK and fluoropyrimidines improves longterm prognosis for curatively resected colorectal cancer. Cancer Biother. Radiopharm., 2008, 23, 461-467
53. Ito, K.; Nakazato, H.; Koike, A.; Takagi, H.; Saji, S.; Baba, S.; Mai, M.; Sakamoto, J.; Ohashi, Y. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int. J. Colorectal Dis., 2004, 19, 157-164 (Pubitemid 38239838)
54. Sakamoto, J.; Morita, S.; Oba, K.; Matsui, T.; Kobayashi, M.; Nakazato, H.; Ohashi, Y. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-Analysis of centrally randomized controlled clinical trials. Cancer Immunol. Immunother., 2006, 55, 404-411 (Pubitemid 43076892)
55. Yoshitani, S.; Takashima, S. Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer. Cancer Biother. Radiopharm., 2009, 24, 35-40
56. Niimoto, M.; Hattori, T.; Tamada, R.; Sugimachi, K.; Inokuchi, K.; Ogawa, N. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn. J. Surg., 1988, 18, 681-686 (Pubitemid 19057878)
57. Toge, T.; Yamaguchi, Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol. Rep., 2000, 7, 1157-1161
58. Takahashi, Y.; Mai, M.; Nakazato, H. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU. Anticancer Res., 2005, 25, 1377-1384 (Pubitemid 40546818)
59. Ueda, Y.; Fujimura, T.; Kinami, S.; Hirono, Y.; Yamaguchi, A.; Naitoh, H.; Tani, T.; Kaji, M.; Yamagishi, H.; Miwa, K. A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC). Jpn. J. Clin. Oncol., 2006, 36, 519-522 (Pubitemid 44592681)